Summary OTC Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Findings Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in China
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in China
Leading company profiles reveal details of key otc pharmaceuticals market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the China otc pharmaceuticals market with five year forecasts
Synopsis Essential resource for top-line data and analysis covering the China otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Reasons To Buy What was the size of the China otc pharmaceuticals market by value in 2015?
What will be the size of the China otc pharmaceuticals market in 2020?
What factors are affecting the strength of competition in the China otc pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in China's otc pharmaceuticals market?
Key Highlights The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.
The Chinese OTC Pharmaceuticals market generated total revenues of $19,005.3m in 2015, representing a compound annual growth rate (CAGR) of 6.2% between 2011 and 2015.
Traditional medicines registered the highest sales value in the Chinese OTC pharmaceuticals market in 2015, with total sales of $7,717.8m, equivalent to 40.6% of the market's overall value.
China's large ageing population and inequity in healthcare provision may be behind the strong growth.
Our reports have been used by over 10K customers, including:
In recent years, China has emerged as the second biggest pharmaceutical market in the world. It is today one of the fastest emerging markets in the pharmaceutical and biotechnology sector globally. A rapidly-ageing population along with a thriving middle class has opened up this market for tremendous opportunities for active pharmaceutical...
245 pages •
By Persistence Market Research
• Sep 2018
REPORT DESCRIPTION This report examines the ‘Global Postoperative Pain Management Market’ for the period 2018–2026. The primary objective of the report is to offer updates and information related to market opportunities in the global Postoperative Pain Management Market. The Postoperative Pain Management...
195 pages •
By BioInformant Worldwide, L.L.C.
• Sep 2018
EXECUTIVE SUMMARY CAR-T cell therapy is a remarkably promising treatment for cancer patients. This emerging treatment is the biggest breakthrough since the introduction of chemotherapy. Already two products (Kymriah and Yescarta) have been approved by the U.S. FDA and European EMA for different cancer indications. What...
Anti-Cancer drugs are the drugs which are used to reduce or prevent the cell proliferation of cancerous tissues. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024; owing to the increasing prevalence of various types of cancer, changing lifestyle & dietary habits, growing aging population, rising...
The immune system is considered as the body’s natural defense against germs. When a germ enters the body, the immune system sends special cells to fight it off. The immune system is not naturally strong enough to prevent a disease from seriously harming a person. But there’s a way to give the immune system a boost,...
Scope of the Report The report titled “Global PD-1 and PD-L1 Inhibitors Market: Size, Trends and Forecasts (2018-2022)”, provides an in depth analysis of the global PD-1 and PD-L1 inhibitors market by value, by cancer, by treatment, by region, etc. The report also provides a detailed analysis of the China PD-1 and PD-L1...